Article Image
News Link • Drugs and Medications

FDA identifies more bogus cancer drugs in U.S

 The U.S. Food and Drug Administration on Tuesday said it has identified a new batch of counterfeit cancer drugs distributed in the United States and is urging doctors to avoid using the products, which contain no active ingredient. 

The fake versions of Swiss drugmaker Roche's widely used cancer drug Avastin are labeled as Altuzan, which is the brand name that Avastin is sold under in Turkey, and do not contain the drug's active ingredient, bevacizumab.


"Packaging or vials found in the U.S. that claim to be Roche's Altuzan with lot number B6021 should be considered counterfeit," FDA said.


The latest discovery follows FDA's notification in February about another counterfeit product that was labeled as Avastin.

Join us on our Social Networks:


Share this page with your friends on your favorite social network: